Mishra Tapas, Lakshmi Kona Kumari, Peddi Kiran Kumar
Department of Minimal Access and Bariatric Surgery, Global Hospitals, Hyderabad, India.
Department of Gastroenterology, Global Hospitals, Hyderabad, India.
Obes Surg. 2016 Oct;26(10):2411-7. doi: 10.1007/s11695-016-2113-4.
Evaluation of the prevalance of cholelithiasis, choledocholithiasis and there management after sleeve gastrectomy, gastric bypass and mini gastric bypass in Indian bariatric patients.
We did a retrospective analysis of our bariatric patient from January 2007 to December 2013 (n = 1397), for prevalence of cholelithiasis and choledocholithiasis. We did synchronous cholecystectomy in all patients planned for bariatric surgery found to have cholelithiasis on USG. Post-operatively, we followed all the patients with gallbladder in situ for minimum of 18-88 months (mean -32.4) and reviewed data for subsequent development of cholelithiasis/choledocholithiasis. Only those patients who were symptomatic underwent intervention.
Prevalence of cholelithiasis and choledocholithiasis in our study was 21.76 and 9.63 %, respectively. The incidence of post-bariatric surgery development of cholelithiasis was 10.53 %; individually, it was 8.42 % in LSG group, 13.4 % in LRYGB group and 12.7 % in MGB patients. The incidence of symptomatic cholelithiasis requiring surgery was 1.94 % after LSG, 4.54 % after LRYGB and 4.25 % after MGB. Post-surgery, six patients developed choledocholithiasis. In our post-bariatric group, the 33 patients who developed symptomatic stones had percentage total weight loss of 30.99 + 4.1 (P < 0.001). The average time period for readmission of symptomatic patient was 11.26 + 2.67 months.
We recommend routine synchronous cholecystectomy with bariatric procedure. In spite of synchronous cholecystectomy, incidence of cholelithiasis in our post-bariatric patient is 10.53 % of which up to one third were symptomatic and required surgery, and incidence of choledocholithiasis is comparable to that of general population.
评估印度肥胖症患者在接受袖状胃切除术、胃旁路手术和迷你胃旁路手术后胆结石、胆总管结石的患病率及其治疗情况。
我们对2007年1月至2013年12月期间的肥胖症患者(n = 1397例)进行了回顾性分析,以了解胆结石和胆总管结石的患病率。对于所有计划接受肥胖症手术且经超声检查发现有胆结石的患者,我们实施了同期胆囊切除术。术后,我们对所有保留胆囊的患者进行了至少18至88个月(平均32.4个月)的随访,并复查了胆结石/胆总管结石后续发生情况的数据。只有出现症状的患者才接受干预治疗。
在我们的研究中,胆结石和胆总管结石的患病率分别为21.76%和9.63%。肥胖症手术后胆结石的发生率为10.53%;具体而言,袖状胃切除术组为8.42%,腹腔镜Roux-en-Y胃旁路手术组为13.4%,迷你胃旁路手术患者为12.7%。需要手术治疗的有症状胆结石的发生率在袖状胃切除术后为1.94%,腹腔镜Roux-en-Y胃旁路手术后为4.54%,迷你胃旁路手术后为4.25%。术后,有6例患者发生了胆总管结石。在我们的肥胖症手术后组中,33例出现有症状结石的患者总体重减轻百分比为30.99±4.1(P < 0.001)。有症状患者再次入院的平均时间为11.26±2.67个月。
我们建议肥胖症手术同时常规进行同期胆囊切除术。尽管进行了同期胆囊切除术,但我们的肥胖症手术后患者中胆结石的发生率仍为10.53%,其中多达三分之一有症状且需要手术治疗,胆总管结石的发生率与普通人群相当。